Skip to main content
Clinical Trials/NCT07623421
NCT07623421CompletedNot Applicable

Comparison of Internal Rotation of the Extremity, Local Cold Application and ShotBlocker on Pain and Comfort During Ventrogluteal Intramuscular Cyanocobalamin Injection: A Randomized Counterbalanced Within-Subjects Clinical Trial

MEDICANA1 site in 1 country215 target enrollmentStarted: July 9, 2019Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
215
Locations
1

Study Overview

Brief Summary

This single-centre, randomized, counterbalanced, within-subjects clinical trial compared four techniques for reducing pain and improving comfort during ventrogluteal intramuscular cyanocobalamin injection in adults. Participants presenting to a family health centre for prescribed vitamin B12 injection each received four injections, one with each technique: standard injection, internal rotation of the extremity, local cold application, and ShotBlocker. Technique order was assigned using a 4 x 4 Latin-square randomization. Pain and comfort were measured immediately after each injection using 0-10 participant-reported scales.

Detailed Description

Adults aged 18 years or older who presented to TOKI Family Health Centre in Sivas, Turkey for prescribed cyanocobalamin intramuscular injection were enrolled between July and December 2019. Each participant received all four ventrogluteal injection techniques across four visits scheduled 24-48 hours apart. The order of techniques was randomized and counterbalanced using a 4 x 4 Latin-square sequence, with allocation concealed in sealed, opaque, sequentially numbered envelopes. Blinding of participants and the administering nurse was not feasible because the procedural techniques were visibly distinct, but the outcome assessor who entered and analyzed pain and comfort scores was blinded to sequence assignment until database lock. All injections were administered by the same experienced registered nurse using cyanocobalamin 1 mg in 1 mL and a 22-gauge, 38-mm needle. Pain was assessed using a 0-10 Visual Analogue Scale and comfort using a 0-10 numerical comfort scale immediately after each injection.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Masking Description

Participants and the administering nurse were not blinded because the procedures were visibly distinct. The outcome assessor who entered and analyzed pain and comfort scores was blinded to sequence assignment until the database was locked.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults aged 18 years or older.
  • Presented to the family health centre for a prescribed course of cyanocobalamin intramuscular injection.
  • Able to read, understand, and respond to study instruments in Turkish.
  • Provided written informed consent.

Exclusion Criteria

  • Contraindication to ventrogluteal intramuscular injection.
  • Local skin lesion, inflammation, edema, scarring, or sensory disturbance over either ventrogluteal site.
  • Body mass index less than 18.5 or greater than 35 kg/m
  • Concurrent regular analgesic or anti-inflammatory use.
  • Chronic pain condition.
  • Clinically diagnosed psychiatric disorder under active treatment.
  • Pregnancy or lactation.
  • Known cold intolerance, cold urticaria, or Raynaud phenomenon.

Investigators

Sponsor
MEDICANA
Sponsor Class
Unknown
Responsible Party
Principal Investigator
Principal Investigator

Ahmet Altun

Principal Investigator

Sivas Medicana Hospital

Study Sites (1)

Loading locations...

Similar Trials